Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liuzhen Capsule
- Development stage
- Preclinical
- Lead developer
- Lei Yun Shang
- Administration
- Oral
01
Overview
Liuzhen Capsule (六珍胶囊) is a Traditional Chinese Medicine (TCM) product currently in the research and development pipeline of Lei Yun Shang, a well-established Chinese pharmaceutical company. Formulated as an oral capsule, it is part of a broader product line that includes Liuzhenbao Gel and Liuzhenbao Oral Liquid. As a TCM formulation, it likely consists of a proprietary blend of herbal ingredients designed to work through multi-target synergistic effects, although its specific molecular targets and primary clinical indications are not disclosed in standard Western pharmaceutical formats on the developer's website. The drug is currently listed as being under research and development by the Lei Yunshang Group Institute of Chinese Medicine.
- Brand names
- Liuzhen Capsule
- Other names
- 六珍胶囊Liuzhen Capsule-Lei Yun Shang
Beyond the preview
Go deeper on Liuzhen Capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Liuzhen Capsule.